Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ferrosoferric Oxide | 12 | 2023 | 40 | 3.400 |
Why?
|
| Magnetic Resonance Imaging | 25 | 2023 | 7702 | 1.710 |
Why?
|
| Positron-Emission Tomography | 13 | 2023 | 2173 | 1.360 |
Why?
|
| Contrast Media | 8 | 2022 | 1472 | 1.160 |
Why?
|
| Cartilage, Articular | 3 | 2022 | 75 | 1.150 |
Why?
|
| Cartilage Diseases | 3 | 2023 | 23 | 1.130 |
Why?
|
| Whole Body Imaging | 6 | 2023 | 114 | 1.030 |
Why?
|
| Fluorodeoxyglucose F18 | 10 | 2023 | 1226 | 0.970 |
Why?
|
| Magnetite Nanoparticles | 3 | 2020 | 50 | 0.930 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2023 | 204 | 0.890 |
Why?
|
| Cell Tracking | 2 | 2023 | 38 | 0.720 |
Why?
|
| Femur Head Necrosis | 1 | 2018 | 11 | 0.670 |
Why?
|
| Bone Marrow Neoplasms | 3 | 2023 | 132 | 0.600 |
Why?
|
| Osteonecrosis | 1 | 2017 | 53 | 0.590 |
Why?
|
| Fractures, Spontaneous | 1 | 2017 | 84 | 0.580 |
Why?
|
| Edema | 2 | 2022 | 267 | 0.580 |
Why?
|
| Multimodal Imaging | 6 | 2020 | 550 | 0.570 |
Why?
|
| Swine | 7 | 2023 | 1541 | 0.560 |
Why?
|
| Bone Diseases | 1 | 2017 | 143 | 0.560 |
Why?
|
| Bone Marrow Diseases | 1 | 2017 | 177 | 0.560 |
Why?
|
| Radiopharmaceuticals | 8 | 2023 | 1301 | 0.550 |
Why?
|
| Swine, Miniature | 4 | 2022 | 67 | 0.490 |
Why?
|
| Osteosarcoma | 1 | 2021 | 929 | 0.480 |
Why?
|
| Brain Diseases | 1 | 2017 | 403 | 0.470 |
Why?
|
| Glucocorticoids | 1 | 2017 | 629 | 0.460 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 1581 | 0.450 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 1360 | 0.420 |
Why?
|
| Heart Diseases | 1 | 2017 | 732 | 0.390 |
Why?
|
| Bone Marrow | 2 | 2022 | 2358 | 0.380 |
Why?
|
| Neoplasms | 9 | 2023 | 15193 | 0.340 |
Why?
|
| Nanoparticles | 3 | 2023 | 554 | 0.340 |
Why?
|
| Bone Neoplasms | 4 | 2023 | 2576 | 0.330 |
Why?
|
| Young Adult | 13 | 2023 | 21445 | 0.330 |
Why?
|
| Gadolinium | 2 | 2021 | 164 | 0.330 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2023 | 341 | 0.330 |
Why?
|
| Leukemia | 1 | 2017 | 1635 | 0.330 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 388 | 0.310 |
Why?
|
| Adolescent | 14 | 2023 | 31252 | 0.300 |
Why?
|
| Brain | 1 | 2020 | 4113 | 0.290 |
Why?
|
| Child | 18 | 2023 | 29154 | 0.280 |
Why?
|
| Stem Cells | 3 | 2023 | 1213 | 0.270 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 833 | 0.230 |
Why?
|
| Sensitivity and Specificity | 3 | 2022 | 4971 | 0.210 |
Why?
|
| Gallium Radioisotopes | 1 | 2022 | 60 | 0.210 |
Why?
|
| Tissue Distribution | 2 | 2021 | 875 | 0.210 |
Why?
|
| Vascular System Injuries | 1 | 2022 | 52 | 0.200 |
Why?
|
| Chondrogenesis | 1 | 2021 | 67 | 0.190 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 131 | 0.190 |
Why?
|
| Staining and Labeling | 2 | 2020 | 429 | 0.190 |
Why?
|
| Pleura | 1 | 2021 | 127 | 0.190 |
Why?
|
| Prospective Studies | 5 | 2023 | 12873 | 0.180 |
Why?
|
| Pediatrics | 2 | 2020 | 1141 | 0.180 |
Why?
|
| Brain Chemistry | 1 | 2020 | 145 | 0.180 |
Why?
|
| Sarcoma | 3 | 2019 | 1725 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2021 | 73 | 0.180 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2023 | 261 | 0.180 |
Why?
|
| Adipose Tissue | 2 | 2022 | 769 | 0.180 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 249 | 0.170 |
Why?
|
| Gadolinium DTPA | 1 | 2019 | 172 | 0.170 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 53 | 0.170 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 755 | 0.170 |
Why?
|
| Bone Regeneration | 1 | 2018 | 32 | 0.170 |
Why?
|
| Treatment Outcome | 5 | 2020 | 32848 | 0.160 |
Why?
|
| Iron | 1 | 2021 | 376 | 0.160 |
Why?
|
| Systems Integration | 1 | 2017 | 76 | 0.150 |
Why?
|
| Adult | 11 | 2023 | 77950 | 0.150 |
Why?
|
| Animals | 9 | 2023 | 59536 | 0.150 |
Why?
|
| Femur | 1 | 2017 | 158 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2023 | 4078 | 0.140 |
Why?
|
| Humans | 24 | 2023 | 261506 | 0.140 |
Why?
|
| Allografts | 1 | 2018 | 650 | 0.140 |
Why?
|
| Observer Variation | 1 | 2017 | 671 | 0.130 |
Why?
|
| Male | 12 | 2023 | 123000 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2021 | 2803 | 0.120 |
Why?
|
| Radiography | 1 | 2019 | 1904 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 14289 | 0.120 |
Why?
|
| Radiology | 1 | 2019 | 434 | 0.110 |
Why?
|
| Organ Preservation | 2 | 2011 | 43 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2018 | 834 | 0.110 |
Why?
|
| Female | 10 | 2022 | 141928 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2022 | 1797 | 0.100 |
Why?
|
| Macrophages | 1 | 2018 | 1304 | 0.100 |
Why?
|
| Receptors, Complement | 1 | 2011 | 48 | 0.100 |
Why?
|
| Brain Death | 1 | 2011 | 53 | 0.090 |
Why?
|
| Cancer Survivors | 1 | 2017 | 650 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2020 | 6100 | 0.090 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 131 | 0.090 |
Why?
|
| Lymphoma | 1 | 2018 | 1467 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2020 | 2967 | 0.080 |
Why?
|
| Cryopreservation | 1 | 2010 | 175 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2023 | 16273 | 0.080 |
Why?
|
| Catheterization | 1 | 2011 | 410 | 0.080 |
Why?
|
| Perfusion | 1 | 2010 | 293 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2021 | 37905 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 6009 | 0.070 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7222 | 0.070 |
Why?
|
| Epiphyses | 1 | 2022 | 13 | 0.060 |
Why?
|
| Cartilage | 1 | 2023 | 128 | 0.050 |
Why?
|
| Kidney | 1 | 2011 | 2146 | 0.050 |
Why?
|
| Knee Joint | 1 | 2022 | 161 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2023 | 13658 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 17523 | 0.050 |
Why?
|
| Prognosis | 1 | 2017 | 21713 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2019 | 127 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 111 | 0.040 |
Why?
|
| Hematinics | 1 | 2019 | 109 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2020 | 553 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 624 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 134 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2017 | 231 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2020 | 5637 | 0.040 |
Why?
|
| Forecasting | 1 | 2019 | 694 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 1648 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 2049 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 862 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 7551 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2018 | 1385 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 4314 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 2011 | 410 | 0.020 |
Why?
|
| Complement Activation | 1 | 2011 | 94 | 0.020 |
Why?
|
| Procaine | 1 | 2010 | 8 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2010 | 20 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2010 | 55 | 0.020 |
Why?
|
| Mannitol | 1 | 2010 | 54 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 3869 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 3719 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2010 | 121 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 148 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 423 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 5047 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2011 | 703 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 14551 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 13310 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 1248 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 6086 | 0.010 |
Why?
|
| Cytokines | 1 | 2011 | 2809 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 34495 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 11538 | 0.010 |
Why?
|